Purdue Pharma L.P. and two affiliated companies are seeking to disqualify a former District of Columbia attorney general from representing the city of Chicago in its lawsuit against several drugmakers for allegedly seeking to misinform the public about the risks and benefits of opium-like pain medications.
According to Purdue, attorney Linda Singer and her law firm law firm Cohen Milstein Sellers & Toll should be disqualified because Singer served as attorney general between Jan. 2, 2007, and Jan. 5, 2008. The District and 26 other jurisdictions reached a $19.5 million settlement with Purdue over the marketing of OxyContin on May 8, 2007, the drugmakers said.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]